1-229634943-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014777.4(URB2):c.330C>A(p.Phe110Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000748 in 1,536,466 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014777.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
URB2 | NM_014777.4 | c.330C>A | p.Phe110Leu | missense_variant | 4/10 | ENST00000258243.7 | |
URB2 | NM_001314021.2 | c.330C>A | p.Phe110Leu | missense_variant | 4/10 | ||
URB2 | XM_005273360.3 | c.330C>A | p.Phe110Leu | missense_variant | 4/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
URB2 | ENST00000258243.7 | c.330C>A | p.Phe110Leu | missense_variant | 4/10 | 1 | NM_014777.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152126Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000508 AC: 10AN: 196738Hom.: 0 AF XY: 0.0000286 AC XY: 3AN XY: 105032
GnomAD4 exome AF: 0.0000751 AC: 104AN: 1384340Hom.: 0 Cov.: 30 AF XY: 0.0000662 AC XY: 45AN XY: 680212
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152126Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74304
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 07, 2022 | The c.330C>A (p.F110L) alteration is located in exon 4 (coding exon 3) of the URB2 gene. This alteration results from a C to A substitution at nucleotide position 330, causing the phenylalanine (F) at amino acid position 110 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at